CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 103,744	$ 126,184
Research and development incentive receivable	509	1,998
Prepaid expenses and other current assets	5,634	1,096
Total current assets	109,887	129,278
Property and equipment, net	421	403
Goodwill	27,109	27,109
Right-of-use assets	1,644	1,959
Other assets	3,473	1,949
Total assets	142,534	160,698
Current liabilities:
Accounts payable	1,838	2,088
Accrued expenses	8,003	6,461
Current portion of lease liability	940	898
Total current liabilities	10,781	9,447
Long-term debt, including accretion, net of discount	25,398	20,097
Lease liabilities	1,445	1,918
Other liabilities	26	16
Total liabilities	37,650	31,478
Commitments and contingencies (Note 9)
Stockholders’ equity:
Common stock, $0.001 par value, 125,000,000 and 33,333,333 shares authorized as of June 30, 2020 and December 31, 2019, respectively; 16,176,154 and 16,128,862 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively	16	16
Additional paid-in capital	263,313	261,367
Accumulated other comprehensive loss	(119)	(119)
Accumulated deficit	(158,326)	(132,044)
Total stockholders’ equity	104,884	129,220
Total liabilities and stockholders’ equity	$ 142,534	$ 160,698